Rm. Obrien et al., HOUSE-DUST MITE IMMUNOTHERAPY RESULTS IN A DECREASE IN DER-P 2-SPECIFIC IFN-GAMMA AND IL-4 EXPRESSION BY CIRCULATING T-LYMPHOCYTES, Clinical and experimental allergy, 27(1), 1997, pp. 46-51
Background Allergen-specific immunotherapy (IT) can be an important ad
junctive therapy in the treatment of allergic disorders. Although it h
as now been used for over 80 yr, the precise mechanism of action remai
ns unclear. Recently a number of studies have shown that cytokine prod
uction may be modified by IT, but different protocols have been used a
nd different results obtained. Objectives The aims of the present stud
y were: (1) to document the allergen-specific expression of interleuki
n-4 (IL-4) and interferon-gamma (IFN-gamma) by peripheral blood cells
in both untreated house dust mite (HDM) allergic patients (non-IT) and
following at least 10 months of HDM-specific IT (post-IT); and (2) to
determine whether alterations in these critical regulatory cytokines
correlated with the clinical outcome of IT. Methods IT was undertaken
with nine fortnightly subcutaneous injections of increasing amounts of
a Dermatophagoides pteronyssinus (Dpt) extract, reaching a final dose
of 10 000 PNU. This was followed by 6- to 8-monthly maintenance injec
tions of 5000 PNU. For cytokine measurement, mononuclear cells were se
parated from peripheral blood and stimulated with the major Dpt allerg
en, Der p 2, for 18 h, after which mRNA was isolated and IL-4 and IFN-
gamma cDNA were amplified by polymerase chain reaction (PCR). The pres
ence of the particular cytokine was determined by visualization follow
ing electrophoresis on an agarose gel. The study was observational in
nature being open and without a placebo group.Results Fifteen Dpt-sens
itive patients who had not received HDM IT (non-IT), and 16 who had, w
ere studied. In the non-IT group, 80% expressed IL-4 and 75% expressed
IFN-gamma. In those post-IT, only 12.5% expressed IL-4 and 19% IFN-ga
mma. The two patients still expressing IL-4 post-IT had had very littl
e clinical response. Six patients were studied both pre- and post-IT.
Prior to IT, three were positive for both cytokines, two positive for
IL-4 alone and one for IFN-gamma. Post-IT, all six were negative for I
L-4 and five were negative for IFN-gamma. Conclusion Allergen-specific
IT results in a reduction in expression of the critical cytokines IL-
4 and IFN-gamma in circulating lymphocytes. It is possible that this i
s a contributary mechanism in the beneficial effect of IT.